150 related articles for article (PubMed ID: 21502281)
1. Evolutionary pathways of transmitted drug-resistant HIV-1.
Pingen M; Nijhuis M; de Bruijn JA; Boucher CA; Wensing AM
J Antimicrob Chemother; 2011 Jul; 66(7):1467-80. PubMed ID: 21502281
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Understanding transmitted HIV resistance through the experience in the USA.
Taiwo B
Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
[TBL] [Abstract][Full Text] [Related]
4. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.
Vignoles M; Barboni G; Agosti MR; Quarleri J; García MK; Ayala SG; Salomón H
Antivir Ther; 2009; 14(8):1175-81. PubMed ID: 20032547
[TBL] [Abstract][Full Text] [Related]
6. The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population.
Pillay D
Antivir Ther; 2001; 6 Suppl 3():15-24. PubMed ID: 11678470
[TBL] [Abstract][Full Text] [Related]
7. Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.
Canducci F; Barda B; Ceresola E; Spagnuolo V; Sampaolo M; Boeri E; Nozza S; Cossarin F; Galli A; Gianotti N; Castagna A; Lazzarin A; Clementi M
Clin Microbiol Infect; 2011 Jun; 17(6):928-34. PubMed ID: 20854427
[TBL] [Abstract][Full Text] [Related]
8. Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.
Canducci F; Marinozzi MC; Sampaolo M; Boeri E; Spagnuolo V; Gianotti N; Castagna A; Paolucci S; Baldanti F; Lazzarin A; Clementi M
J Antimicrob Chemother; 2010 Mar; 65(3):425-33. PubMed ID: 20056687
[TBL] [Abstract][Full Text] [Related]
9. Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
Capiluppi B; Saracco A; Gianotti N; Mussini C; Butini L; Tomasoni L; De Gennaro M; Rizzolo L; Monolo G; Cargnel A; Moioli C; Arici C; Portelli V; Rizzardini G; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):73-8. PubMed ID: 12003179
[TBL] [Abstract][Full Text] [Related]
10. Can modulation of viral fitness represent a target for anti-HIV-1 strategies?
Clementi M
New Microbiol; 2004 Jul; 27(3):207-14. PubMed ID: 15460522
[TBL] [Abstract][Full Text] [Related]
11. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Narciso P; Lazzarin A
Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.
Wensing AM; van de Vijver DA; Angarano G; Asjö B; Balotta C; Boeri E; Camacho R; Chaix ML; Costagliola D; De Luca A; Derdelinckx I; Grossman Z; Hamouda O; Hatzakis A; Hemmer R; Hoepelman A; Horban A; Korn K; Kücherer C; Leitner T; Loveday C; MacRae E; Maljkovic I; de Mendoza C; Meyer L; Nielsen C; Op de Coul EL; Ormaasen V; Paraskevis D; Perrin L; Puchhammer-Stöckl E; Ruiz L; Salminen M; Schmit JC; Schneider F; Schuurman R; Soriano V; Stanczak G; Stanojevic M; Vandamme AM; Van Laethem K; Violin M; Wilbe K; Yerly S; Zazzi M; Boucher CA;
J Infect Dis; 2005 Sep; 192(6):958-66. PubMed ID: 16107947
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance in variants from the female genital tract and plasma.
Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
[TBL] [Abstract][Full Text] [Related]
14. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus.
Gandhi RT; Wurcel A; Rosenberg ES; Johnston MN; Hellmann N; Bates M; Hirsch MS; Walker BD
Clin Infect Dis; 2003 Dec; 37(12):1693-8. PubMed ID: 14689353
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.
Paraskevis D; Magiorkinis E; Katsoulidou A; Hatzitheodorou E; Antoniadou A; Papadopoulos A; Poulakou G; Paparizos V; Botsi C; Stavrianeas N; Lelekis M; Chini M; Gargalianos P; Magafas N; Lazanas M; Chryssos G; Petrikkos G; Panos G; Kordossis T; Theodoridou M; Sypsa V; Hatzakis A;
Virus Res; 2005 Sep; 112(1-2):115-22. PubMed ID: 16022906
[TBL] [Abstract][Full Text] [Related]
16. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.
SPREAD programme
AIDS; 2008 Mar; 22(5):625-35. PubMed ID: 18317004
[TBL] [Abstract][Full Text] [Related]
17. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
[TBL] [Abstract][Full Text] [Related]
18. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Martinez-Picado J; Martínez MA
Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
[TBL] [Abstract][Full Text] [Related]
20. Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.
Hance AJ; Lemiale V; Izopet J; Lecossier D; Joly V; Massip P; Mammano F; Descamps D; Brun-Vézinet F; Clavel F
J Virol; 2001 Jul; 75(14):6410-7. PubMed ID: 11413308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
